NDAORALTABLET, EXTENDED RELEASE
Approved
Jul 2016
Lifecycle
Peak
Competitive Pressure
0/100
Data completeness
2/8 — Basic
Drug data last refreshed 11h ago · AI intelligence enriched 6d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
VIEKIRA XR is a fixed-dose combination oral tablet containing dasabuvir sodium, ombitasvir, paritaprevir, and ritonavir, approved in 2016 for hepatitis C virus (HCV) treatment. This extended-release formulation targets multiple viral proteins to achieve direct-acting antiviral activity. The combination represents a once-daily regimen designed to simplify HCV therapy and improve patient adherence.
Peak8.3 years to LOE
Product is at peak lifecycle stage with established market presence; commercial teams are focused on optimization and market maintenance rather than growth expansion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on VIEKIRA XR positions you in a stable, mature commercial environment within AbbVie's hepatology portfolio. Roles emphasize sustained market management, payer relationships, and real-world outcomes rather than launch intensity, making it suitable for professionals seeking established product expertise and long-term commercial stability.
Brand ManagerField Sales Representative
Worked on VIEKIRA XR at AbbVie? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.